In fact, the established role of WNK-SPAK/OSR1 signaling pathway in stimulating NKCC1 and inhibiting KCC3, which contribute to the pathogenesis of stroke, are the reasons for our recent pharmacological studies [70,71]. This evidence concerns the gene STK39 and Stroke.